The Discounted Cash Flow (DCF) valuation of Charles River Laboratories International Inc (CRL) is 212.75 USD. With the latest stock price at 152.89 USD, the upside of Charles River Laboratories International Inc based on DCF is 39.2%.
Based on the latest price of 152.89 USD and our DCF valuation, Charles River Laboratories International Inc (CRL) is a buy. buying CRL stocks now will result in a potential gain of 39.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.6% | 7.7% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 142.54 - 379.40 | 212.75 |
| Upside | -6.8% - 148.1% | 39.2% |